Joint (NASDAQ:JYNT) Lowered to Sell at StockNews.com

Joint (NASDAQ:JYNTGet Rating) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.

A number of other research firms have also recently commented on JYNT. Lake Street Capital lowered their price target on Joint from $150.00 to $100.00 in a report on Friday, February 25th. Zacks Investment Research upgraded Joint from a “sell” rating to a “hold” rating in a research report on Thursday. Craig Hallum lowered their price objective on Joint from $117.00 to $90.00 in a research note on Monday, January 24th. B. Riley decreased their price target on Joint from $125.00 to $88.00 in a research report on Friday, February 25th. Finally, DA Davidson reduced their price objective on Joint from $128.00 to $69.00 and set a “buy” rating for the company in a report on Friday, February 25th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Joint has an average rating of “Buy” and a consensus target price of $85.33.

Shares of NASDAQ JYNT opened at $30.52 on Friday. Joint has a one year low of $29.84 and a one year high of $111.06. The firm has a market capitalization of $441.35 million, a PE ratio of 63.58 and a beta of 1.27. The company has a current ratio of 1.25, a quick ratio of 1.25 and a debt-to-equity ratio of 0.07. The business has a 50-day moving average price of $35.56 and a two-hundred day moving average price of $57.75.

Joint (NASDAQ:JYNTGet Rating) last announced its quarterly earnings data on Thursday, February 24th. The company reported $0.01 EPS for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.07). Joint had a return on equity of 26.30% and a net margin of 8.82%. The business had revenue of $22.43 million for the quarter, compared to analyst estimates of $22.21 million. During the same quarter in the previous year, the business posted $0.12 earnings per share. Research analysts anticipate that Joint will post 0.33 EPS for the current year.

In related news, CFO Jake Singleton acquired 1,515 shares of the company’s stock in a transaction on Wednesday, March 16th. The stock was acquired at an average price of $33.00 per share, with a total value of $49,995.00. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Peter D. Holt acquired 1,500 shares of Joint stock in a transaction that occurred on Wednesday, March 16th. The stock was purchased at an average cost of $33.24 per share, for a total transaction of $49,860.00. The disclosure for this purchase can be found here. 6.10% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Raymond James & Associates raised its holdings in shares of Joint by 3.1% during the third quarter. Raymond James & Associates now owns 4,214 shares of the company’s stock worth $413,000 after purchasing an additional 128 shares during the last quarter. Captrust Financial Advisors grew its stake in shares of Joint by 117.6% during the third quarter. Captrust Financial Advisors now owns 285 shares of the company’s stock worth $28,000 after purchasing an additional 154 shares in the last quarter. State Board of Administration of Florida Retirement System grew its stake in shares of Joint by 4.5% during the third quarter. State Board of Administration of Florida Retirement System now owns 4,433 shares of the company’s stock worth $435,000 after purchasing an additional 190 shares in the last quarter. Raymond James Financial Services Advisors Inc. boosted its stake in Joint by 3.9% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 5,109 shares of the company’s stock valued at $501,000 after acquiring an additional 191 shares in the last quarter. Finally, Swiss National Bank boosted its stake in Joint by 0.6% in the third quarter. Swiss National Bank now owns 31,400 shares of the company’s stock valued at $3,078,000 after acquiring an additional 200 shares in the last quarter. Institutional investors own 86.71% of the company’s stock.

Joint Company Profile (Get Rating)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.

See Also

Analyst Recommendations for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.